Anja Bastian
City of Hope(US)University of Oklahoma Health Sciences Center(US)
Publications by Year
Research Areas
Synthesis and biological activity, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, Mitochondrial Function and Pathology, Cancer Genomics and Diagnostics
Most-Cited Works
- → Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression(2014)75 cited
- → The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents(2014)47 cited
- → Discovery of Antitubulin Agents with Antiangiogenic Activity as Single Entities with Multitarget Chemotherapy Potential(2014)44 cited
- → AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization(2016)41 cited
- → Interleukin 6 Function in the Skin and Isolated Keratinocytes Is Modulated by Hyperglycemia(2019)41 cited
- → The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents(2015)40 cited
- → Targeting dormant micrometastases: rationale, evidence to date and clinical implications(2016)30 cited
- → A Small Molecule with Anticancer and Antimetastatic Activities Induces Rapid Mitochondrial-Associated Necrosis in Breast Cancer(2015)28 cited
- → Synthesis and biological activity of 5-chloro-N4-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents(2013)19 cited
- → Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo[3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple-acting angiokinase inhibition as antitumor agents(2016)18 cited